

The prevalence of overweight and obesity in China has continued to increase over the last decade, with mounting health and economic consequences. In this Personal View, we critically examine recent advances and identify current and emerging challenges in obesity across public health and policy, clinical research, and practice. National policy frameworks, technical health and nutrition guidelines, and multisectoral collaboration have elevated obesity on the public agenda. Evidence supporting lifestyle interventions and medications for obesity continues to accumulate.
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet